lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A

Hai-Ting Liu1,2, Yong-Xin Zou1, Wen-Jie Zhu1

  • 1Key Laboratory for Experimental Teratology of the Ministry of Education and Department of Pathology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, P.R. China.

Insights

This study reveals THAP7-AS1, a long noncoding RNA, promotes gastric cancer (GC) progression by enhancing CUL4B nuclear entry. Targeting THAP7-AS1 offers a potential therapeutic strategy for GC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Long noncoding RNAs (lncRNAs) are implicated in cancer, but their roles in gastric cancer (GC) are not fully understood.
  • Identifying novel molecular regulators is crucial for developing effective GC therapies.

Purpose of the Study:

  • To elucidate the function and mechanism of THAP7-AS1 in gastric cancer.
  • To investigate THAP7-AS1 as a potential therapeutic target for GC.

Main Methods:

  • lncRNA microarray analysis to identify differentially expressed lncRNAs in GC.
  • Investigation of transcriptional regulation by SP1 and m6A modification by METTL3.
  • Functional assays to assess the impact of THAP7-AS1 on GC cell progression and metastasis.
  • Mechanism studies involving protein-RNA interactions, nuclear import, and downstream signaling pathways.

Main Results:

  • THAP7-AS1 was significantly upregulated in GC tissues and correlated with poor prognosis and lymph node metastasis.
  • SP1 transcriptionally activated THAP7-AS1, while METTL3-mediated m6A modification enhanced its expression.
  • THAP7-AS1 promoted GC cell progression by facilitating CUL4B nuclear entry, leading to repression of miR-22-3p and miR-320a, and activation of the PI3K/AKT pathway.
  • Inhibition of THAP7-AS1 suppressed GC growth, invasion, and metastasis.

Conclusions:

  • THAP7-AS1 acts as an oncogene in gastric cancer through a novel mechanism involving CUL4B nuclear translocation.
  • THAP7-AS1 is a promising molecular target for GC therapy.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.6K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.6K